GE Expands Its Waste-to-Energy Capabilities

Waste management

GE Expands Its Waste-to-Energy Capabilities

03 Dec, 2010

Published over 15 years ago. See the latest and most current information on Waste management.

Further expanding its diverse portfolio of power generation technologies, GE announce the acquisition of substantially all of the assets of Calnetix Power Solutions (CPS), a Florida-based company that develops innovative technology for small-scale, waste heat to power projects. Recovering waste heat from industrial processes and using it to produce electricity is a rapidly growing trend in the global power industry offering high efficiency and a reduced carbon footprint.

CPS offers well-proven waste heat to power technology to generate electricity using the waste heat of various types of engines, biomass boilers and gas turbines. The acquired business will be integrated into GE’s Jenbacher gas engine business, based in Jenbach, Austria. Today, much of the activity in the small-scale, waste heat recovery sector is centered in Europe.

“Alternative energy sources such as waste heat are growing in importance given the urgent global need for more efficient use of our limited resources. Acquiring CPS’s technology gives us a tremendous opportunity to enter this very promising, small-scale waste heat to power segment with a competitive, fully commercialized offering. Because of its energy efficiency and zero emissions, we see this industry sector as a $1 billion global space with high growth opportunities,” said Steve Bolze, president and CEO of GE Power & Water.

Latest News

Explore Our Other Sites

Labmate Online
Scientists solve 80-year-old riddle of why virus-infected cells behave so differently
Explore more Arrow
Envirotech Online
New civil penalties and real-time monitoring raise the bar for water company compliance
Explore more Arrow
Petro Online
Fifty years on, the EU reaffirms its commitment to Seveso-level industrial safety oversight
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow